EMMAUS LIFE SCIENCES INC (EMMA)
EMMA moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How EMMA actually reacts to news — the realized, point-in-time move the market made, measured across 82 labeled events over the last three years with zero look-ahead.
EMMA’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 20% | 49 |
| 30-min | 0.00% | 25% | 53 |
| 60-min | 0.00% | 24% | 55 |
| to close | 0.00% | 23% | 60 |
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when EMMA moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to EMMA's baseline. Nothing else.
Recent EMMA events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Emmaus Life Sciences Announces Agreement for Evaluation of L-glutamine for Pancreatic Cancer | Press release | Business Wire | -18.20% | -31.85% | |
| Emmaus Life Sciences Reports Quarterly Financial Results | Press release | Business Wire | +0.00% | -8.00% | |
| Form 10-Q Emmaus Life Sciences, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | +0.00% | |
| Form 8-K Emmaus Life Sciences, For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | — | +0.00% | |
| Emmaus Life Sciences Reports Quarterly Financial Results | Press release | Business Wire | — | — | |
| Form 10-Q Emmaus Life Sciences, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 8-K Emmaus Life Sciences, For: May 15 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K Emmaus Life Sciences, For: Apr 16 | SEC filing · Form 8-K | SEC EDGAR | +24.48% | -24.48% | |
| Form 8-K Emmaus Life Sciences, For: Apr 13 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +11.11% | |
| Form 10-K Emmaus Life Sciences, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Emmaus Life Sciences, For: Mar 30 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Emmaus Life Sciences Reports Annual Financial Results | Press release | Business Wire | +0.00% | +0.00% | |
| Form 8-K Emmaus Life Sciences, For: Mar 02 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K Emmaus Life Sciences, For: Dec 24 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Emmaus Life Sciences Announces Strategic Transaction | Press release | Business Wire | +0.00% | +0.00% | |
| Form 8-K Emmaus Life Sciences, For: Dec 17 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +7.50% | |
| Form 8-K Emmaus Life Sciences, For: Dec 15 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +5.10% | |
| Emmaus Life Sciences Reports Quarterly Financial Results | Press release | PR Newswire | — | +0.00% | |
| Form 10-Q Emmaus Life Sciences, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Emmaus Life Sciences, For: Nov 14 | SEC filing · Form 8-K | SEC EDGAR | -11.11% | -25.93% | |
| Emmaus Life Sciences Reports Quarterly Financial Results | Press release | PR Newswire | — | +0.00% | |
| Form 10-Q Emmaus Life Sciences, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | +0.00% | |
| Form 8-K Emmaus Life Sciences, For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | +7.02% | +8.77% | |
| Form 8-K Emmaus Life Sciences, For: Jun 30 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Emmaus Life Sciences Receives FDA Approval for Endari® Label Enhancements | Press release | PR Newswire | +9.68% | -3.23% | |
| Emmaus Life Sciences Reports Quarterly Financial Results | Press release | PR Newswire | +0.00% | +0.00% | |
| Form 10-Q Emmaus Life Sciences, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 8-K Emmaus Life Sciences, For: May 15 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Emmaus Life Sciences, For: May 02 | SEC filing · Form 8-K | SEC EDGAR | -0.66% | -13.91% | |
| Emmaus Life Sciences Reports 2024 Financial Results | Press release | PR Newswire | +6.25% | +0.00% | |
| Form 10-K Emmaus Life Sciences, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +6.25% | +0.00% | |
| Form 8-K Emmaus Life Sciences, For: Apr 14 | SEC filing · Form 8-K | SEC EDGAR | +6.25% | +0.00% | |
| Form NT 10-K Emmaus Life Sciences, For: Dec 31 | SEC filing · Form NT | SEC EDGAR | +13.33% | +13.33% | |
| Emmaus Life Science Reports Grant of Endari Market Exclusivity In Kingdom of Saudi Arabia | Press release | PR Newswire | +0.00% | +16.43% | |
| Emmaus Life Sciences Reports Improved Quarterly Financial Results | Press release | PR Newswire | +0.00% | +0.00% | |
| Form 10-Q Emmaus Life Sciences, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Emmaus Life Sciences, For: Nov 19 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form NT 10-Q Emmaus Life Sciences, For: Sep 30 | SEC filing · Form NT | SEC EDGAR | +0.00% | +29.89% | |
| Form 8-K Emmaus Life Sciences, For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Emmaus Life Sciences, For: Oct 22 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +53.46% | |
| Form 8-K Emmaus Life Sciences, For: Sep 30 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Emmaus Life Sciences Reports Quarterly Financial Results | Press release | PR Newswire | — | — | |
| Form 10-Q Emmaus Life Sciences, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 10-Q Emmaus Life Sciences, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 8-K Emmaus Life Sciences, For: Sep 05 | SEC filing · Form 8-K | SEC EDGAR | -8.00% | -8.00% | |
| Form NT 10-Q Emmaus Life Sciences, For: Jun 30 | SEC filing · Form NT | SEC EDGAR | +0.00% | +0.00% | |
| Emmaus Life Sciences Announces Willis C. Lee as Chief Executive Officer | Press release | PR Newswire | — | — | |
| Form 8-K Emmaus Life Sciences, For: Jul 15 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program | Press release | PR Newswire | +0.00% | +0.00% | |
| Emmaus Life Sciences Reports 2023 Financial Results | Press release | PR Newswire | +0.00% | +0.00% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the EMMA section they belong to.
Where else EMMA is measured.
EMMA earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is EMMAUS LIFE SCIENCES INC's median reaction calculated?
Every labeled EMMA news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 82 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 25% of EMMA's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does EMMA's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.